• SEC and FDA Announce New Referral Program
  • March 17, 2004
  • Law Firm: Covington & Burling LLP - New York Office
  • The Food and Drug Administration and the Securities and Exchange Commission have announced new streamlined measures to gather and share information to assist the SEC in its investigations of pharmaceutical companies that provide misleading information to investors.